Sustained Release Excipients Market : Latest Innovations, Future Scope and Market Trends

Sustained Release Drugs: Significant Benefits over Conventional Dosage Forms

Based on therapeutic need, flexible drug formulation can be designed to provide immediate release, delayed release, or sustained release. Sustained release formulation is designed to release a drug at a predetermined rate by maintaining constant drug concentration for a specific period of time. Most commonly used drug delivery systems for sustained release drugs are parenteral injections and implants.

Report Overview @ https://www.transparencymarketresearch.com/sustained-release-drugs-market.html

Sustained release drugs offer several advantages over conventional ones. These include better patient compliance, low dosing frequency, reduced incidence of side effects, and overall cost reduction of medical care.

A number of companies are investing in oral or injectable sustained release drug manufacturing. Sanofi's AMBIEN CR (zolpidem tartrate) tablet is an oral extended release tablet for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance. Eli Lilly and Company's PROZAC fluoxetine delayed-release capsule is administered orally in combination with olanzapine for the treatment of depressive episodes associated with bipolar disorder.
Get a Glimpse of the In-depth Analysis through our Sustained Release Drugs Market Report Brochure

Key Drivers and Restraints of Global Sustained Release Drugs Market

Rise in demand for pediatric and geriatric sustained release dosage forms drives the global market. Extended release drugs are majorly used to reduce dosing frequency. Non-compliance of pediatric and geriatric patients is a concern due to issues related to poor taste of medications and swallowing difficulties of the drugs. Nanotechnology, micronization, and drug stabilization methods are used for dose reduction in these sustained release drugs.

Request PDF Sample of Sustained Release Excipients Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73323

Hence, sustained release drugs have been widely accepted compared to immediate release formulations of the same drug. This type of drug offers extended release over a long period of time, leading to better patient compliance and increased bioavailability.

Dose dumping is a major restraint of the global sustained release drugs market. If the system fails, dose dumping could occur which can lead to toxicity. Dose dumping is defined as rapid release of sustained release drugs in the circulatory system. High cost of drugs is another factor likely to hamper market growth. A single unit of sustained release drug costs higher than conventional dosage form.
Oral Route of Administration to Witness High Demand

In terms route of administration, the global sustained release drugs market can be classified into oral, intramuscular, subcutaneous, transdermal, intravenous, and others

Oral is the most preferred route of drug delivery. This is primarily due to higher flexibility, better patient compliance, and reduced dosing frequency. Moreover, reasonable cost of oral extended drug delivery system over oral conventional drugs drives the segment.

In 2017, Pfizer, Inc. received the FDA approval for LYRICA CR (Pregabalin) extended-release tablets for the treatment of neuropathic pain associated with diabetic peripheral neuropathy (pDPN)

Buy Now "Sustained Release Excipients Market" Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=73323<ype=S

Hospital Pharmacies Segment to Witness Strong Growth

Based on distribution channel, the global sustained release drugs market can be bifurcated into hospital pharmacies and online pharmacies

Sustained release drugs are available over-the-counter and on prescription. Hospital pharmacies deal with procurement, storage, dispensing, and distribution of drugs for inpatients as well as outpatients.

Sustained release tablets are composed of multiple layers for different drug release times. Some of the more common prefixes or suffixes for sustained-release, controlled-release, or controlled-delivery products are 12-hour, 24-hour, CC, CD, CR, ER, LA, Retard, SA, Slo-, SR, XL, XR, or XT.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Sustained Release Drugs Market Report

Asia Pacific Market to Expand at a High CAGR

In terms of region, the global sustained release drugs can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America held the largest share of the global market in 2018 due to continuous investment in R&D and availability of highly sophisticated technologies. Moreover, advanced research facilities and presence of leading pharmaceutical and biopharmaceutical companies boost the growth of the market in the region.

However, the market in Asia Pacific is expected to expand at the highest CAGR during the forecast period owing to developing health care infrastructure and continuous investment by companies in lower and middle income countries in the region.

Key Manufacturers Operating in Global Market

The global sustained release drugs market was highly fragmented in 2018. Key manufacturers operating in the global market are:

Pfizer, Inc.
Sanofi
Endo Pharmaceuticals, Inc.
Janssen Global Services, LLC
Eli Lilly and Company
Alkermes
Genentech, Inc.
Novartis AG
Abbott
Ipsen Pharma
Merck & Co.
AstraZeneca
Allergan

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.